Zuranolone for treatment of major depressive disorder: a systematic review and meta-analysis

BackgroundCurrent treatment modalities for Major Depressive Disorder have variable efficacies and a variety of side effects. To amend this, many trials for short term, well tolerated monotherapies are underway. One such option is Zuranolone (SAGE-217), which is a recent FDA approved antidepressant f...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Abdullah Ahmad, Abdul Rafeh Awan, Natasha Nadeem, Aamir Shahid Javed, Mobeen Farooqi, Muhammed Daniyal, Hassan Mumtaz
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2024-04-01
Serie:	Frontiers in Neuroscience
Soggetti:	Zuranolone major depressive disorder depression postpartum depression antidepressants essential tremors
Accesso online:	https://www.frontiersin.org/articles/10.3389/fnins.2024.1361692/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!